Cellgate, Inc.
Records under this name other than patents Cellgate, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,605,115 | Method and composition for inhibiting cardiovascular cell proliferation Formerly held Term ended Term ended Jun 19, 2020 · From the USPTO record | Term ended | Term ended Jun 19, 2020 | From the USPTO record |
| US 8,623,833 | Compositions and methods for enhancing drug delivery across and into epithelial tissues Formerly held Lapsed on the fee record Ended Jan 7, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jan 7, 2018 | From the USPTO record |
| US 7,585,834 | Transporters Comprising Spaced Arginine Moieties Formerly held Lapsed on the fee record Ended Sep 8, 2017 · Medium confidence | Lapsed on the fee record | Ended Sep 8, 2017 | Medium confidence |
| US 8,278,264 | Compositions and methods for enhancing drug delivery across and into ocular tissues Formerly held Lapsed on the fee record Ended Oct 2, 2016 · From the USPTO record | Lapsed on the fee record | Ended Oct 2, 2016 | From the USPTO record |
| US 6,794,545 | Conformationally restricted polyamine analogs as disease therapies Lapsed on the fee record Ended Sep 21, 2016 · From the USPTO record | Lapsed on the fee record | Ended Sep 21, 2016 | From the USPTO record |
| US 6,759,387 | Compositions and methods for enhancing drug delivery across and into epithelial tissues Formerly held Lapsed on the fee record Ended Jul 6, 2016 · From the USPTO record | Lapsed on the fee record | Ended Jul 6, 2016 | From the USPTO record |
| US 6,730,293 | Compositions and methods for treating inflammatory diseases of the skin Formerly held Lapsed on the fee record Ended May 4, 2016 · From the USPTO record | Lapsed on the fee record | Ended May 4, 2016 | From the USPTO record |
| US 6,669,951 | Compositions and methods for enhancing drug delivery across and into epithelial tissues Formerly held Lapsed on the fee record Ended Dec 30, 2015 · From the USPTO record | Lapsed on the fee record | Ended Dec 30, 2015 | From the USPTO record |
| US 6,649,587 | Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases Lapsed on the fee record Ended Nov 18, 2015 · From the USPTO record | Lapsed on the fee record | Ended Nov 18, 2015 | From the USPTO record |
| US 7,279,502 | Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases Lapsed on the fee record Ended Oct 9, 2015 · From the USPTO record | Lapsed on the fee record | Ended Oct 9, 2015 | From the USPTO record |